Trial site
Sarah Cannon Research Institute
- 12running trials
- 9closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Pancreatic cancer5 trials
- Colorectal cancer4 trials
- Melanoma4 trials
- Prostate cancer4 trials
- Sarcoma4 trials
- Childhood cancers3 trials
- Endometrial cancer3 trials
- Gastric and oesophageal cancer3 trials
- Kidney cancer3 trials
- Liver and biliary tract cancer3 trials
- Head and neck cancer2 trials
- and 11 more
- Phase
- Phase 1/29 trials
- Phase 17 trials
- Phase 24 trials
- Phase 31 trial
- Status
- Active, not recruiting8 trials
- Completed6 trials
- Recruiting4 trials
- Terminated3 trials
- Lead sponsor
- Amgen2 trials
- Immuneering Corporation2 trials
- Novartis Pharmaceuticals2 trials
- USWM CT, LLC2 trials
- Affimed GmbH1 trial
- and 12 more
Running trials
Recruiting
Recruiting
Recruiting
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Recruiting
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Active, not recruiting
First in Human Study of TORL-3-600 in Participants With Advanced Cancer
Active, not recruiting
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Active, not recruiting
Active, not recruiting
A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors
Active, not recruiting
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
Active, not recruiting
Active, not recruiting
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Pancreatic cancer2 recruiting
- Prostate cancer2 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Endometrial cancer1 recruiting
- Head and neck cancer1 recruiting
- Kidney cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Melanoma1 recruiting
- Mesothelioma1 recruiting
- Ovarian cancer1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Completed
Terminated
Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL
Completed
Terminated
Terminated
A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
Completed
Completed
Completed
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma
Completed
A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer
Site data: ClinicalTrials.govUpdated 12 Nov 2026